SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-047532
Filing Date
2021-09-10
Accepted
2021-09-10 07:19:53
Documents
77
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q omga-10q_20210630.htm   iXBRL 10-Q 2962218
2 EX-31.1 omga-ex311_9.htm EX-31.1 19348
3 EX-31.2 omga-ex312_6.htm EX-31.2 19217
4 EX-32.1 omga-ex321_8.htm EX-32.1 9453
5 EX-32.2 omga-ex322_7.htm EX-32.2 9272
  Complete submission text file 0001564590-21-047532.txt   9085189

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA omga-20210630.xsd EX-101.SCH 61026
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE omga-20210630_cal.xml EX-101.CAL 42147
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE omga-20210630_def.xml EX-101.DEF 230015
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE omga-20210630_lab.xml EX-101.LAB 428714
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE omga-20210630_pre.xml EX-101.PRE 362040
11 EXTRACTED XBRL INSTANCE DOCUMENT omga-10q_20210630_htm.xml XML 1433273
Mailing Address 20 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 20 ACORN PARK DRIVE CAMBRIDGE MA 02140 (617) 949-4360
Omega Therapeutics, Inc. (Filer) CIK: 0001850838 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40657 | Film No.: 211245847
SIC: 2836 Biological Products, (No Diagnostic Substances)